A comprehensive comparison between camelid nanobodies and single chain variable fragments
Abstract By the emergence of recombinant DNA technology, many antibody fragments have been developed devoid of undesired properties of natural immunoglobulins. Among them, camelid heavy-chain variable domains (VHHs) and single-chain variable fragments (scFvs) are the most favored ones. While scFv is...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/51458c53b6ff42df89fdb9ce86ae855e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:51458c53b6ff42df89fdb9ce86ae855e |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:51458c53b6ff42df89fdb9ce86ae855e2021-12-05T12:07:04ZA comprehensive comparison between camelid nanobodies and single chain variable fragments10.1186/s40364-021-00332-62050-7771https://doaj.org/article/51458c53b6ff42df89fdb9ce86ae855e2021-12-01T00:00:00Zhttps://doi.org/10.1186/s40364-021-00332-6https://doaj.org/toc/2050-7771Abstract By the emergence of recombinant DNA technology, many antibody fragments have been developed devoid of undesired properties of natural immunoglobulins. Among them, camelid heavy-chain variable domains (VHHs) and single-chain variable fragments (scFvs) are the most favored ones. While scFv is used widely in various applications, camelid antibodies (VHHs) can serve as an alternative because of their superior chemical and physical properties such as higher solubility, stability, smaller size, and lower production cost. Here, these two counterparts are compared in structure and properties to identify which one is more suitable for each of their various therapeutic, diagnosis, and research applications.Yasaman AsaadiFatemeh Fazlollahi JouneghaniSara JananiFatemeh RahbarizadehBMCarticleSingle-chain variable fragment (scFv)camelid VHHnanobodysingle-domain antibodyTherapeutics. PharmacologyRM1-950ENBiomarker Research, Vol 9, Iss 1, Pp 1-20 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Single-chain variable fragment (scFv) camelid VHH nanobody single-domain antibody Therapeutics. Pharmacology RM1-950 |
spellingShingle |
Single-chain variable fragment (scFv) camelid VHH nanobody single-domain antibody Therapeutics. Pharmacology RM1-950 Yasaman Asaadi Fatemeh Fazlollahi Jouneghani Sara Janani Fatemeh Rahbarizadeh A comprehensive comparison between camelid nanobodies and single chain variable fragments |
description |
Abstract By the emergence of recombinant DNA technology, many antibody fragments have been developed devoid of undesired properties of natural immunoglobulins. Among them, camelid heavy-chain variable domains (VHHs) and single-chain variable fragments (scFvs) are the most favored ones. While scFv is used widely in various applications, camelid antibodies (VHHs) can serve as an alternative because of their superior chemical and physical properties such as higher solubility, stability, smaller size, and lower production cost. Here, these two counterparts are compared in structure and properties to identify which one is more suitable for each of their various therapeutic, diagnosis, and research applications. |
format |
article |
author |
Yasaman Asaadi Fatemeh Fazlollahi Jouneghani Sara Janani Fatemeh Rahbarizadeh |
author_facet |
Yasaman Asaadi Fatemeh Fazlollahi Jouneghani Sara Janani Fatemeh Rahbarizadeh |
author_sort |
Yasaman Asaadi |
title |
A comprehensive comparison between camelid nanobodies and single chain variable fragments |
title_short |
A comprehensive comparison between camelid nanobodies and single chain variable fragments |
title_full |
A comprehensive comparison between camelid nanobodies and single chain variable fragments |
title_fullStr |
A comprehensive comparison between camelid nanobodies and single chain variable fragments |
title_full_unstemmed |
A comprehensive comparison between camelid nanobodies and single chain variable fragments |
title_sort |
comprehensive comparison between camelid nanobodies and single chain variable fragments |
publisher |
BMC |
publishDate |
2021 |
url |
https://doaj.org/article/51458c53b6ff42df89fdb9ce86ae855e |
work_keys_str_mv |
AT yasamanasaadi acomprehensivecomparisonbetweencamelidnanobodiesandsinglechainvariablefragments AT fatemehfazlollahijouneghani acomprehensivecomparisonbetweencamelidnanobodiesandsinglechainvariablefragments AT sarajanani acomprehensivecomparisonbetweencamelidnanobodiesandsinglechainvariablefragments AT fatemehrahbarizadeh acomprehensivecomparisonbetweencamelidnanobodiesandsinglechainvariablefragments AT yasamanasaadi comprehensivecomparisonbetweencamelidnanobodiesandsinglechainvariablefragments AT fatemehfazlollahijouneghani comprehensivecomparisonbetweencamelidnanobodiesandsinglechainvariablefragments AT sarajanani comprehensivecomparisonbetweencamelidnanobodiesandsinglechainvariablefragments AT fatemehrahbarizadeh comprehensivecomparisonbetweencamelidnanobodiesandsinglechainvariablefragments |
_version_ |
1718372252644278272 |